Dr Brendan Pang
obtained the FRCPath (UK) and qualified as a histopathologist. He then trained in the Diagnostic Molecular Oncology Centre (DMOC), a College of American Pathologists (CAP) accredited molecular diagnostic laboratory under the mentorship of Professor Manuel Salto-Tellez. He furthered his training in molecular pathology as a visiting scholar at the University of Pittsburgh Medical Centre’s (UPMC) Molecular Anatomic Pathology (MAP) laboratory, Presbyterian Hospital, under Dr Marina Nikiforova, chair-elect of the solid tumours sub-division of the Association of Molecular pathology (AMP) and returned to Singapore as the Director of DMOC.
He was appointed as an honorary pathology fellow at the Cancer Science Institute (CSI) in 2012 and has had research collaborations with the Genome Institute of Singapore (GIS) and other Principal Investigators from the Yong Loo Lin School of Medicine. His research interests lie in the development of novel biomarker assays using molecular platforms.